A bipartisan group of 25 House members yesterday asked Health and Human Services Secretary Xavier Becerra to clarify by Sept. 9 whether and how the Administration plans to enforce Medicare’s 96-hour payment rule and condition of participation for critical access hospitals after the COVID-19 public health emergency.

The rule requires CAHs to certify inpatients will be discharged or transferred to another hospital within 96 hours of admission to receive payment. A related Medicare condition of participation requires CAH inpatient stays to remain below 96 hours on an annual average basis. HHS has not prioritized enforcement of the rule since 2018 due to its financial burden on hospitals and waived the condition of participation in response to the COVID-19 public health emergency.

“Even after the PHE formally ends, COVID and other respiratory diseases are likely to cause some patients to need hospitalizations lasting longer than 96 hours,” the representatives wrote (LINK). “These and other patients who can safely and effectively be treated in their local hospital deserve the option of receiving care closer to their homes, families, and usual doctors.”
 

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…